3,870
Views
38
CrossRef citations to date
0
Altmetric
Report

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting

, , , , , , , , , , , & show all
Pages 87-98 | Received 10 Jul 2015, Accepted 06 Oct 2015, Published online: 23 Nov 2015